Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
Sofetabart mipitecan received FDA breakthrough therapy designation for platinum-resistant ovarian cancer after prior ...
StemWave acoustic wave therapy is now available in DuBois, Western Pennsylvania through Mercy Family Health, offering FDA-cleared technology that increases blood circulation and targets nerve damage ...
Please provide your email address to receive an email when new articles are posted on . Multiple diagnostic tools are necessary to assess diabetic peripheral neuropathy in patients. The choice of ...